Taken together, these findings in vivo and in vitro demonstrates that CML disruptes feedback regulation in the diabetic kidney by increasing HMG-CoAR-mediated cholesterol synthesis and LDLr-mediated cholesterol uptake, which cause renal structure and function damage, and ultimately, promotes the development and progress of DN. The gene discussed is LDLR; the disease is liver dysplastic nodule.